Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two different furazolidone regimens for Helicobacter pylori eradication
IRCT2016011826084N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of furazolidone in Helicobacter pylori infection and Peptic ulcer disease (PUD), sponsored by Golestan University of Medical Sciences. Started Mar 2015; status: completed.
02
Drugs
furazolidone
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on IRCT2016011826084N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016011826084N1.